Open Live Account
BEST TRADING FOR RECIVE REBATE
Login

By

admin
(Bloomberg) — Gold and U.S. stocks could part ways during a fresh round of market turbulence, ending a three-month period in which their returns were almost yoked. Renewed deterioration of the global economy and more lockdowns to prevent Covid-19 from spreading should hit equities but leave gold standing, according to Societe Generale (OTC:SCGLY). “While the...
Read More
By Tom Westbrook and Chris Prentice SINGAPORE/WASHINGTON (Reuters) – The dollar languished and just about everything else rose on Thursday, as markets took patchy U.S. economic data as a harbinger of ever more stimulus and brinkmanship on Capitol Hill as a sign that a deal on a new U.S. stimulus package is close. Following Wall...
Read More
(Reuters) – The U.S. Food and Drug Administration on Wednesday approved GlaxoSmithKline’s (L:GSK) experimental treatment for a common form of blood cancer. GSK’s belantamab mafodotin, or BLENREP, was approved for treating adults with relapsed and refractory multiple myeloma who no longer respond to treatment with an immunomodulatory agent, the drugmaker said in a statement. Multiple...
Read More
1 18 19 20

Text Widget

Nulla vitae elit libero, a pharetra augue. Nulla vitae elit libero, a pharetra augue. Nulla vitae elit libero, a pharetra augue. Donec sed odio dui. Etiam porta sem malesuada.

Our Cases

Tag Cloud